Ultralife Corporation (ULBI)
| Market Cap | 98.61M +29.4% |
| Revenue (ttm) | 187.86M +8.4% |
| Net Income | -8.21M |
| EPS | -0.49 |
| Shares Out | 16.66M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,988 |
| Open | 6.14 |
| Previous Close | 6.13 |
| Day's Range | 5.77 - 6.27 |
| 52-Week Range | n/a |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 8, 2026 |
About ULBI
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commerci... [Read more]
Financial Performance
Financial StatementsNews
Ultralife Earnings Call Transcript: Q1 2026
Q1 2026 saw revenue and gross margin declines due to shipment delays, plant shutdowns, and one-time costs, but a record backlog and new product launches position the business for future growth. Focus remains on operational improvements and vertical integration.
Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2026 as follows:
Ultralife Corporation to Report First Quarter Results on May 8, 2026
NEWARK, N.Y., May 01, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2026 before the market opens on Friday, May 8, ...
Ultralife Earnings Call Transcript: Q4 2025
Q4 2025 revenue rose 10.6% year-over-year, but a one-time impairment led to a net loss. Backlog reached $110 million, and operational improvements and new product launches position the company for growth and margin expansion in 2026.
Ultralife reports Q4 EPS (45c) vs 1c last year
Reports Q4 revenue $48.5M vs $43.852M last year. “During the fourth quarter we took a number of decisive actions to remove structural and manufacturing inefficiencies from our global operations. For…
Ultralife Corporation Reports Fourth Quarter Results
NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows:
Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026
NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday,...
Ultralife Earnings Call Transcript: Q3 2025
Q3 2025 saw revenue growth to $43.4M but a net loss of $0.07 per share due to one-time costs and supply chain issues. Strategic actions included facility consolidation, new product launches, and a completed Electric Chem integration, positioning for improved margins and growth in 2026.
Ultralife reports Q3 EPS (7c) vs 2c last year
Reports Q3 revenue $43.4M vs $35.7M last year. “Although revenue grew 2.5% organically and 21.5% including the Electrochem acquisition for the third quarter, supply chain issues caused manufacturing i...
Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results:
Ultralife Corporation to Report Third Quarter Results on November 18, 2025
NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, N...
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Comm...
Ultralife receives $5.2M award from U.S. DLA for BA-5390 batteries
Ultralife (ULBI) has received an award valued at approximately $5.2M from the U.S. Government’s Defense Logistics Agency for its lithium manganese dioxide, non-rechargeable BA-5390 military batteries....
Ultralife Corporation Receives Award for Its BA-5390 Military Batteries from U.S. Defense Logistics Agency
NEWARK, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received an award valued at approximately $5.2 million from the U.S. Government's Defense Logistics Agency (“D...
Ultralife Earnings Call Transcript: Q2 2025
Q2 2025 saw higher revenues but lower margins and profits due to tariffs, product mix, and order delays. Integration of Electrochem is progressing, debt reduction is ahead of schedule, and new product pipelines are strengthening, with optimism for a rebound in the second half of 2025.
Ultralife reports Q2 adjusted EPS 7c vs 22c last year
Reports Q2 revenue $48.6M vs $42.983M last year. “The second quarter was a challenging period for Ultralife (ULBI). While the addition of Electrochem lifted revenue, Battery & Energy Products organic…
Ultralife Corporation to Report Second Quarter Results on August 7, 2025
NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, Augu...
Ultralife Earnings Call Transcript: Q1 2025
Q1 2025 saw 21% revenue growth to $50.7M, driven by strong government defense sales and the full inclusion of Electrochem, despite lower medical and communication systems sales. Gross margin declined to 25.1% due to product mix and one-time costs, but backlog and cash flow remain strong.
Ultralife reports Q1 adjusted EPS 13c vs 21c last year
Reports Q1 revenue $50.746M vs $41.927M last year. “We delivered a strong first quarter with a 21% revenue increase year over year. Robust organic growth in our Battery & Energy…
Ultralife Earnings Call Transcript: Q4 2024
Q4 2024 revenue was $43.9M with net income of $0.2M, impacted by one-time Electrochem acquisition costs. The backlog remains strong at $102.2M, and integration of Electrochem is progressing, with new product launches and lean initiatives supporting a positive 2025 outlook.
Ultralife reports Q4 EPS 1c vs 17c last year
Reports Q4 revenue $43.9M vs $44.5M last year. “For the fourth quarter the contribution of Electrochem compensated for delays in the timing of expected larger orders for our Communications Systems…
Ultralife Corporation to Report Fourth Quarter Results on April 1, 2025
NEWARK, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2024 before the market opens on Tuesday,...
Ultralife Corporation to Report Fourth Quarter Results on March 11, 2025
NEWARK, N.Y., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2024 before the market opens on Tuesday, ...
Ultralife appoints Luke as Chief Marketing Officer
Ultralife (ULBI) announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President – Sales & Business Development, Battery & Energy Products, effective Janua...
Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans
Appoints Chief Marketing Officer and Senior Vice President – Sales & Business Development, Battery & Energy Products Appoints Chief Marketing Officer and Senior Vice President – Sales & Business Devel...